News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
684,975 Results
Type
Article (39037)
Company Profile (157)
Press Release (645781)
Section
Business (207974)
Career Advice (1896)
Deals (34946)
Drug Delivery (84)
Drug Development (78784)
Employer Resources (146)
FDA (15607)
Job Trends (15203)
News (344952)
Policy (32674)
Tag
Academia (2710)
Africa (719)
Alabama (33)
Allergies (41)
Alliances (45650)
Alzheimer's disease (1141)
Antibody-drug conjugate (ADC) (55)
Approvals (15549)
Arizona (120)
Artificial intelligence (50)
Asia (40829)
Australia (6659)
Bankruptcy (319)
Best Places to Work (11839)
Biosimilars (60)
C2C Services and Suppliers (77089)
California (844)
Canada (650)
Cancer (205)
Career advice (1531)
CAR-T (39)
Cell therapy (77)
China (50)
Clinical research (61196)
Collaboration (65)
Colorado (37)
COVID-19 (2253)
Cystic fibrosis (72)
Diabetes (37)
Diagnostics (6309)
Diversity, equity & inclusion (39)
Drug pricing (52)
Earnings (91716)
Employer resources (118)
Europe (90847)
Events (118355)
FDA (15652)
Florida (107)
Funding (39)
Gene therapy (59)
GLP-1 (517)
Government (4680)
Healthcare (20293)
Hotbed/Location (475829)
Idaho (57)
Illinois (212)
Indiana (110)
Infectious disease (2268)
Inflammatory bowel disease (93)
Interviews (319)
IPO (16661)
Job creations (3398)
Job search strategy (1367)
Kansas (88)
Layoffs (408)
Legal (7586)
Liver cancer (56)
Lung cancer (43)
Maine (52)
Management (41)
Manufacturing (54)
Maryland (270)
Massachusetts (466)
Medical device (13924)
Medtech (13927)
Mergers & acquisitions (18018)
Metabolic disorders (179)
Neuroscience (1227)
New Jersey (64)
New York (85)
NextGen Class of 2024 (7036)
Non-profit (4973)
North Carolina (180)
Obesity (122)
Opinion (183)
Parkinson's disease (31)
Patents (37)
Peanut (37)
Pennsylvania (56)
People (54748)
Phase I (19032)
Phase II (27132)
Phase III (20429)
Policy (33)
Postmarket research (2172)
Preclinical (8018)
Rare diseases (94)
Real estate (5692)
Recruiting (54)
Regulatory (21153)
Reports (33)
Research institute (2418)
Resumes & cover letters (335)
South America (1115)
Startups (3296)
Texas (91)
United States (3108)
Vaccines (396)
Washington State (117)
Weight loss (117)
Date
Today (46)
Last 7 days (517)
Last 30 days (1994)
Last 365 days (40518)
2024 (22879)
2023 (42380)
2022 (53017)
2021 (57344)
2020 (56700)
2019 (50588)
2018 (37411)
2017 (33680)
2016 (33120)
2015 (38527)
2014 (31629)
2013 (26799)
2012 (28035)
2011 (28758)
2010 (25653)
684,975 Results for "20".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Longeveron® to Present at the Virtual Life Sciences Investor Forum on June 20, 2024
Longeveron Inc. today announced that it will participate in the Virtual Life Sciences Investor Forum taking place June 20, 2024.
June 17, 2024
·
1 min read
Pharm Country
Combined General Meeting of June 20, 2024 - Availability of the preparatory documents
Inventiva announced the availability of the preparatory documents for the Combined General Meeting of June 20, 2024.
May 30, 2024
·
9 min read
Lone Star Bio
VenoStent Completes $20 Million Series A with $4 Million Investment from Norwest Venture Partners
VenoStent, Inc. announced that it closed an additional $4 million from Norwest Venture Partners to round out its Series A financing at $20 million with Good Growth Capital and IAG Capital Partners co-leading the deal.
June 27, 2024
·
4 min read
BioForest
RareCyte secures $20M financing to expand the Orion™ Spatial Biology platform including Multiplex Assay Reagents, Software and Precision Biology Services
RareCyte, Inc. announced today the completion of a $20M financing from new and existing investors.
June 27, 2024
·
2 min read
Deals
Grifols completes sale of a 20% equity stake in SRAAS and forges strategic alliance with Haier Group
Grifols, a global healthcare company and leading manufacturer of plasma-derived medicines, announced it has completed the sale of a 20% equity stake in Shanghai RAAS to Haier Group Corporation and forged a strategic alliance with Haier Group.
June 18, 2024
·
7 min read
Biotech Beach
Xencor Regains CD20 x CD3 Bispecific T-Cell Engager
Xencor, Inc. announced it will regain exclusive worldwide rights to plamotamab, a CD20 x CD3 bispecific T-cell engager, which Xencor advanced through Phase 1 clinical development in hematologic cancers.
June 13, 2024
·
5 min read
Pharm Country
Indaptus Therapeutics to Present Positive Data on Lead Product Candidate, Decoy20, at STING & TLR-Targeted Therapies Summit
Indaptus Therapeutics, Inc. announced that its founder and Chief Scientific Officer, Michael Newman, Ph.D., will present additional data on the Company’s lead product candidate, Decoy20, at the 5th Annual STING & TLR-Targeted Therapies Summit in San Diego on June 19-20, 2024.
June 11, 2024
·
8 min read
Daxor Corporation to Showcase the Benefits of BVA-100™ Guided-Care at the American Association of Heart Failure Nurses (AAHFN) 20th Annual Meeting
Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today it will exhibit at the American Association of Heart Failure Nurses (AAHFN) 20th Annual Meeting from June 20-22nd, 2024 at the Rosen Shingle Creek Resort in Orlando, Florida.
June 18, 2024
·
3 min read
Business
Frontier Medicines Appoints Gerardo Ubaghs as Chief Financial Officer and Announces $20 Million Series C Extension
Frontier Medicines Corporation announced the appointment of Gerardo Ubaghs as Chief Financial Officer and the additional close of $20 million extension to its Series C, bringing the total amount raised to $100 million, with the financing slated to accelerate multiple pipeline programs.
June 25, 2024
·
3 min read
Business
Taro to Release Full Year Results on May 20, 2024
Taro Pharmaceutical Industries Ltd. announced that it plans to release its financial results for year ended March 31, 2024, after the close of market on Monday, May 20, 2024.
May 15, 2024
·
1 min read
1 of 68,498
Next
